QuantLogix ← CME scorecard
📅 CME Earnings Preview
CME Group Inc.
Next report (est.)
September 4, 2026
Countdown
83 days
EPS growth YoY
+21.4%
Revenue growth YoY
+14.5%
Implied vs actual — last 8 reports
ReportOptions impliedActual moveMarket was
April 24, 2026 ±2.8% -0.1% over-priced
October 24, 2025 ±2.1% +0.2% over-priced
July 25, 2025 ±1.8% +0.9% over-priced
April 30, 2025 ±2.6% +1.7% over-priced
November 8, 2024 ±2.1% +1.6% over-priced
August 5, 2024 ±2.1% -1.3% over-priced
May 1, 2024 ±2.1% -0.8% over-priced
November 1, 2023 ±2.4% -1.2% over-priced
Across these reports, options implied an average ±2.3% move vs an actual average of 1.0% — the stock stayed inside the implied band 100% of the time.
Fundamentals into the print
QuarterEPS (dil.)RevenueNet income
Q1 FY2026 $3.18 $1.9B $1.2B
Q4 FY2025 $3.24 $1.6B $1.2B
Q3 FY2025 $2.49 $1.5B $908M
Q2 FY2025 $2.81 $1.7B $1.0B
Analyst posture
Buy / Strong Buy
10
Hold
8
Sell
3
Stable: +0 net change 30d
Live 5-factor engine read: Buy · 65/100 Full scorecard →
Get alerted before every CME report — free Full live analysis
🤖 Pro runs a 10-agent AI debate on CME before the print — 5 analysts, bull vs bear, a risk read, and a trader's verdict. See Pro →

CME Group Inc. (CME) reports in 83 days, with the next report estimated for September 4, 2026. Across the last 8 reports, options priced an average ±2.3% earnings move while the stock actually moved 1.0% on average — the market has systematically over-priced CME's earnings risk. Fundamentals into the print: EPS up 21.4% year-over-year, revenue up 14.5%. QuantLogix's live 5-factor engine currently reads CME as a buy at 65/100.

Implied move is derived from at-the-money option pricing; actual moves are close-to-close on report days. Next-report dates are estimates until confirmed by the company. Educational market analysis, not investment advice. Browse all signal scorecards →